Integrating the quality of the cytotoxic response and tumor susceptibility into the design of protective vaccines in tumor immunotherapy
J. Clin. Invest. Salem Chouaib, et al. 111:595
doi:10.1172/JCI18044 [Go to this article.]

Problems with a PDF?